Where is BioQual located?

BioQual is headquartered in Rockville, United States. It is registered at Rockville, Maryland.

How many employees does BioQual have?

As of Aug 31, 2026, the latest employee count at BioQual is 169.

Where does BioQual rank among its competitors?

BioQual ranks 4th amongst 227 active competitors, of which 12 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was RxCelerate, which secured an undisclosed amount in Feb, 2024.

Who are the top competitors of BioQual?

BioQual's top competitors include Tigermed, Gubra and Yashraj Biotechnology. Among them, RxCelerate secured the most recent funding round in February, 2024.

BioQual - 2026 Company Profile, Team & Competitors

BioQual is a public company based in Rockville (United States), founded in 1981 by John Landon. It operates as an Integrated CRO focused on infectious diseases. The company has 227 active competitors, including 12 funded and 42 that have exited. Its top competitors include companies like Tigermed, Gubra and Yashraj Biotechnology.

Company Details

BioQual performs contract research services focused on in vivo models of human diseases including AIDS, influenza, RSV infection, Flavivirus infections including Zika and Dengue, malaria, hepatitis, and cancer. Bioqual's laboratories are actively involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. In vitro services are available for evaluation of immunologic, virologic, and molecular parameters. These services include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, etc.

Website: bioqual.com
Social
Registered Address: Rockville, Maryland

Key Metrics

Founded Year

1981

Location

Rockville, United States

Stage

Public

Ranked

4^th among 227 active competitors

Employee Count

169 as on Aug 31, 2026

Similar Companies

Tigermed & 275 more

Exit Details

Public

View BioQual's full profile

BioQual is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BIOQUAL, INC. CIN: 133078199 , United States, Active	Dec 26, 999	-	235 (As on Dec 31, 2024)	-

BioQual got listed on Jan 13, 2000.

Click here to take a look at BioQual's IPO in detail

BioQual has not raised any funding rounds yet.

The founders of BioQual is John Landon.

Here are the details of BioQual's key team members:

John Landon: Founder of BioQual.

View details of BioQual's Founder profiles and Board Members

BioQual's employee count trend

BioQual has 169 employees as of Aug 26. Here is BioQual's employee count trend over the years:

Uncover BioQual's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of BioQual include Tigermed, Gubra and Yashraj Biotechnology. Here is the list of Top 10 competitors of BioQual, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Tigermed 2004, Hangzhou (China), Public	Provider of drug development and pre clinical services	-	CDG Capital, Qiming Venture Partners	51/100
2nd	Gubra 2008, Horsholm (Denmark), Public	Preclinical CRO focussed on developing treatments for NAFLD/NASH, diabetes, and obesity	-	-	49/100
3rd	Yashraj Biotechnology 1999, Mumbai (India), Early Stage	Provider of recombinant antigens and antibodies for diagnostic and research	$492K	Supreme Industries, CFM & 4 others	49/100
4th	BioQual 1981, Rockville (United States), Public	Integrated CRO focused on infectious diseases	-	-	48/100
5th	Gentronix 1999, Alderley Edge (United Kingdom), Acquired	Providr of in-vitro and in-vivo genetic toxicology screening services	$3.84M	NVM, Mercia	47/100
6th	RxCelerate 2012, Babraham (United Kingdom), Seed	Provider of pre-clinical contract research services	-	Total Medical Ventures	41/100
7th	GV Research Platform 2020, Hyderabad (India), Funding Raised	Provides platform for conducting research and drug development services	-	JV Ventures	41/100
8th	ReveraGen 2008, Rockville (United States), Funding Raised	Developer of steroids for treating Duchenne muscular dystrophy	-	FDA, NINDS & 10 others	41/100
9th	Absorption 1996, Exton (United States), Acquired	Premier life science service provider offering comprehensive R&D and manufacturing solutions	-	-	41/100
10th	Shanghai Semero Biotechnology 2014, Shanghai (China), Series C	Provider of diversified preclinical services for brain-related disorders	$20.8M	GF Xinde Investment Management, Tianrui Fengnian Private Equity Fund ... & 8 others	41/100